In vitro effect of biological and conventional disease-modifying antirheumatic drugs on fibrocyte differentiation in patients with rheumatoid arthritis and healthy controls
Saved in:
Main Authors: | Helene Broch Tenstad, Pernille Just Vinholt, Christian Nielsen, Hanne Lindegaard, Søren Andreas Just |
---|---|
Format: | article |
Language: | EN |
Published: |
AVES Yayincilik
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b20e9e7443864b1fa7afc47c62c455d8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In vitro evaluation of disease-modifying antirheumatic drugs against rheumatoid arthritis associated pathogens of the oral microflora
by: Stefan Winkler, et al.
Published: (2021) -
Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis.
by: Gia Deyab, et al.
Published: (2021) -
Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
by: Anne Mirjam Kerola, et al.
Published: (2021) -
Assessing the effectiveness of synthetic and biologic disease-modifying antirheumatic drugs in psoriatic arthritis – a systematic review
by: Kingsley GH, et al.
Published: (2015) -
Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms
by: Ivan Padjen, et al.
Published: (2020)